In vitro anticancer, antioxidant, antimicrobial, antileishmanial, enzymes inhibition and in vivo anti-inflammatory activities of organotin(IV) derivatives of 4-bromophenoxyacetic acid

Shahnaz Rahim,Abdul Sadiq,Aneela Javed,Maciej Kubicki,Benson Kariuki,Mohammad Assad,Niaz Muhammad,Nighat Fatima,Momin Khan,Abdullah F. AlAsmari,Fawaz Alasmari
DOI: https://doi.org/10.1016/j.molstruc.2024.138703
IF: 3.841
2024-05-28
Journal of Molecular Structure
Abstract:Organotin(IV) derivatives {( n -C 4 H 9 ) 3 SnL ( 1 ), (CH 3 ) 3 SnL ( 2 ), ( n -C 4 H 9 ) 2 SnL 2 ( 3 ) and (CH 3 ) 2 SnL 2 ( 4 )} of 4-bromophenoxyacetic acid ( HL ) were synthesized and characterized by elemental, FT-IR, NMR and single crystal XRD diffraction analyses. The carboxylate ligand showed bridging/chelating bidentate coordination. The complexes 1 and 2 have adopted polymeric chain structures consisting tin atoms in distorted trigonal bipyramidal geometry. Complex 3 has shown highest DPPH radical scavenging (IC 50 = 33.46 μg/mL) and antileishmanial activity (IC 50 = 27.06 μg/mL). Complex 3 was also the most efficient agent in acetylcholinesterase (IC 50 = 5.12 μg/mL), butyrylcholinesterase (IC 50 = 13.79 μg/mL) and Monoamine oxidase (IC 50 = 8.50 μg/mL) inhibition assays. Complex 4 (IC 50 = 18.73 μg/mL) was the most potent ABTS radical scavenger. Complex 1 with IC 50 values of 27.50 and 71.32 μg/mL was the most efficient α-glucosidase and dipeptidyl peptidase-4 enzyme inhibitor, respectively. While complex 2 was found the most potent Cyclooxygenase-2 (7.81 μg/mL) and 5-Lioxygenase (6.69 μg/mL) inhibitor. MTT assay revealed highest inhibitory potency of complexes 4 (IC 50 = 8.035 ± 0.05 μg/ml), and 1 (IC 50 = 10.16±0.17 μg/ml) towards the brain cancer cell line. The in vivo study performed on mice have shown potent anti-inflammatory effects of 1 and 2 comparable to the standard, indomethacin.
chemistry, physical
What problem does this paper attempt to address?